Cardiac Marker Testing Market Scope and Size by 2031
Cardiac markers involve enzymes, hormones, and proteins of various forms and are used in the patients for diagnosis and risk stratification regarding chest pain and presumed acute coronary syndrome. They identify the blood level and heart functioning. These substances are released into the blood at the time when the heart is stressed or damaged, and look out for any problems such as coronary syndrome and blockage in blood flow. The measurement of these markers helps to diagnose different heart syndromes, such as acute coronary syndrome and cardiac ischemia. The cardiac marker testing provides great specificity and can help in the identification of the conditions in the early stages of presentation like troponins; they are expected to be the fastest-growing segment in the whole cardiology market.
MARKET SCOPE
The "Global Cardiac Marker Testing Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cardiac marker testing market with detailed market segmentation by product type, biomarker type, application, end user, and geography. The report provides key statistics on the market status of the leading cardiac marker testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the global cardiac marker testing market is segmented into reagents and kits and instruments.
- On the basis of biomarker type, the market is bifurcated into troponin I and T, CK-MB, BNP, myoglobin, hs-CRP and other biomarkers.
- On the basis of application, the market is bifurcated into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and ischemia.
- On the basis of end-users, the market is bifurcated into laboratory testing, point-of-care-testing and others.
MARKET DYNAMICS
Drivers
- The rising prevalence of cardiovascular diseases and increasing geriatric population drive the global cardiac marker testing market.
- Stimulating the ongoing clinical trials to identify novel cardiac markers and increased research and development activities in cardiac markers boosts the market growth.
- The growing investment from public and private organizations on cardiac biomarkers fuels the market growth.
- Increased healthcare expenditure and modernization of healthcare infrastructure by a larger population base propel the growth of the market.
Restraints
- Factors like technical problems regarding sample collection and storage.
- Issues related to regulatory and reimbursement systems.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac marker testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac marker testing market in these regions.
IMPACT OF COVID-19 ON CARDIAC MARKER TESTING MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and impacted the overall global market. The cardiac marker testing market faced a period of negative growth, which can be attributed to factors such as massive footfall in the number of patients visiting hospitals with cardiovascular conditions and those diagnosed with myocardial infarction. As strict guidelines were imposed in all areas of cardiology service hence, significant reductions can be seen in all areas, including outpatient clinics, investigations, procedures, and cardiology community services. But the increase in patient pool and relaxation in lockdown will result in the sustainable growth of the market.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac marker testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac marker testing market in these regions.
IMPACT OF COVID-19 ON CARDIAC MARKER TESTING MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and impacted the overall global market. The cardiac marker testing market faced a period of negative growth, which can be attributed to factors such as massive footfall in the number of patients visiting hospitals with cardiovascular conditions and those diagnosed with myocardial infarction. As strict guidelines were imposed in all areas of cardiology service hence, significant reductions can be seen in all areas, including outpatient clinics, investigations, procedures, and cardiology community services. But the increase in patient pool and relaxation in lockdown will result in the sustainable growth of the market.
MARKET PLAYERS
The report covers key developments in the cardiac marker testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from cardiac marker testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cardiac marker testing in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cardiac marker testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Roche Diagnostics Ltd
- Abbott Laboratories
- Siemens Healthineers AG
- Danaher Corporation
- Ortho Clinical Diagnostics
- Randox laboratories Ltd.
- bioMérieux SA
- LSI Medience Corporation
- DiaSorin S.p.A.
- Bio-Rad Laboratories, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cardiac Marker Testing Market - By Product Type
1.3.2 Cardiac Marker Testing Market - By Biomarker Type
1.3.3 Cardiac Marker Testing Market - By Application
1.3.4 Cardiac Marker Testing Market - By End User
1.3.5 Cardiac Marker Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CARDIAC MARKER TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. CARDIAC MARKER TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CARDIAC MARKER TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CARDIAC MARKER TESTING - GLOBAL MARKET OVERVIEW
6.2. CARDIAC MARKER TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS AND KITS
7.3.1. Overview
7.3.2. Reagents and Kits Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.4.3. Chemiluminescence Market
7.4.3.1. Overview
7.4.3.2. Chemiluminescence Market Forecast and Analysis
7.4.4. Immunofluorescence Market
7.4.4.1. Overview
7.4.4.2. Immunofluorescence Market Forecast and Analysis
7.4.5. ELISA Market
7.4.5.1. Overview
7.4.5.2. ELISA Market Forecast and Analysis
7.4.6. Immunochromatography Market
7.4.6.1. Overview
7.4.6.2. Immunochromatography Market Forecast and Analysis
8. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - BIOMARKER TYPE
8.1. OVERVIEW
8.2. BIOMARKER TYPE MARKET FORECASTS AND ANALYSIS
8.3. TROPONIN I AND T
8.3.1. Overview
8.3.2. Troponin I and T Market Forecast and Analysis
8.4. CK-MB
8.4.1. Overview
8.4.2. CK-MB Market Forecast and Analysis
8.5. BNP
8.5.1. Overview
8.5.2. BNP Market Forecast and Analysis
8.6. MYOGLOBIN
8.6.1. Overview
8.6.2. Myoglobin Market Forecast and Analysis
8.7. HS-CRP
8.7.1. Overview
8.7.2. Hs-CRP Market Forecast and Analysis
8.8. OTHER BIOMARKERS
8.8.1. Overview
8.8.2. Other Biomarkers Market Forecast and Analysis
9. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MYOCARDIAL INFARCTION
9.3.1. Overview
9.3.2. Myocardial Infarction Market Forecast and Analysis
9.4. CONGESTIVE HEART FAILURE
9.4.1. Overview
9.4.2. Congestive Heart Failure Market Forecast and Analysis
9.5. ACUTE CORONARY SYNDROME
9.5.1. Overview
9.5.2. Acute Coronary Syndrome Market Forecast and Analysis
9.6. ATHEROSCLEROSIS
9.6.1. Overview
9.6.2. Atherosclerosis Market Forecast and Analysis
9.7. ISCHEMIA
9.7.1. Overview
9.7.2. Ischemia Market Forecast and Analysis
10. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. LABORATORY TESTING
10.3.1. Overview
10.3.2. Laboratory Testing Market Forecast and Analysis
10.4. POINT-OF-CARE-TESTING
10.4.1. Overview
10.4.2. Point-Of-Care-Testing Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. CARDIAC MARKER TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Cardiac Marker Testing Market Overview
11.1.2 North America Cardiac Marker Testing Market Forecasts and Analysis
11.1.3 North America Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.1.4 North America Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.1.5 North America Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.1.6 North America Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.1.7 North America Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.1.7.1 Canada Cardiac Marker Testing Market
11.1.7.1.1 Canada Cardiac Marker Testing Market by Product Type
11.1.7.1.2 Canada Cardiac Marker Testing Market by Biomarker Type
11.1.7.1.3 Canada Cardiac Marker Testing Market by Application
11.1.7.1.4 Canada Cardiac Marker Testing Market by End User
11.1.7.2 Mexico Cardiac Marker Testing Market
11.1.7.2.1 Mexico Cardiac Marker Testing Market by Product Type
11.1.7.2.2 Mexico Cardiac Marker Testing Market by Biomarker Type
11.1.7.2.3 Mexico Cardiac Marker Testing Market by Application
11.1.7.2.4 Mexico Cardiac Marker Testing Market by End User
11.1.7.3 US Cardiac Marker Testing Market
11.1.7.3.1 US Cardiac Marker Testing Market by Product Type
11.1.7.3.2 US Cardiac Marker Testing Market by Biomarker Type
11.1.7.3.3 US Cardiac Marker Testing Market by Application
11.1.7.3.4 US Cardiac Marker Testing Market by End User
11.2. EUROPE
11.2.1 Europe Cardiac Marker Testing Market Overview
11.2.2 Europe Cardiac Marker Testing Market Forecasts and Analysis
11.2.3 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.2.4 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.2.5 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.2.6 Europe Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Cardiac Marker Testing Market
11.2.7.1.1 Germany Cardiac Marker Testing Market by Product Type
11.2.7.1.2 Germany Cardiac Marker Testing Market by Biomarker Type
11.2.7.1.3 Germany Cardiac Marker Testing Market by Application
11.2.7.1.4 Germany Cardiac Marker Testing Market by End User
11.2.7.2 France Cardiac Marker Testing Market
11.2.7.2.1 France Cardiac Marker Testing Market by Product Type
11.2.7.2.2 France Cardiac Marker Testing Market by Biomarker Type
11.2.7.2.3 France Cardiac Marker Testing Market by Application
11.2.7.2.4 France Cardiac Marker Testing Market by End User
11.2.7.3 Italy Cardiac Marker Testing Market
11.2.7.3.1 Italy Cardiac Marker Testing Market by Product Type
11.2.7.3.2 Italy Cardiac Marker Testing Market by Biomarker Type
11.2.7.3.3 Italy Cardiac Marker Testing Market by Application
11.2.7.3.4 Italy Cardiac Marker Testing Market by End User
11.2.7.4 Spain Cardiac Marker Testing Market
11.2.7.4.1 Spain Cardiac Marker Testing Market by Product Type
11.2.7.4.2 Spain Cardiac Marker Testing Market by Biomarker Type
11.2.7.4.3 Spain Cardiac Marker Testing Market by Application
11.2.7.4.4 Spain Cardiac Marker Testing Market by End User
11.2.7.5 United Kingdom Cardiac Marker Testing Market
11.2.7.5.1 United Kingdom Cardiac Marker Testing Market by Product Type
11.2.7.5.2 United Kingdom Cardiac Marker Testing Market by Biomarker Type
11.2.7.5.3 United Kingdom Cardiac Marker Testing Market by Application
11.2.7.5.4 United Kingdom Cardiac Marker Testing Market by End User
11.2.7.6 Rest of Europe Cardiac Marker Testing Market
11.2.7.6.1 Rest of Europe Cardiac Marker Testing Market by Product Type
11.2.7.6.2 Rest of Europe Cardiac Marker Testing Market by Biomarker Type
11.2.7.6.3 Rest of Europe Cardiac Marker Testing Market by Application
11.2.7.6.4 Rest of Europe Cardiac Marker Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Cardiac Marker Testing Market Overview
11.3.2 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.3.5 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Cardiac Marker Testing Market
11.3.7.1.1 Australia Cardiac Marker Testing Market by Product Type
11.3.7.1.2 Australia Cardiac Marker Testing Market by Biomarker Type
11.3.7.1.3 Australia Cardiac Marker Testing Market by Application
11.3.7.1.4 Australia Cardiac Marker Testing Market by End User
11.3.7.2 China Cardiac Marker Testing Market
11.3.7.2.1 China Cardiac Marker Testing Market by Product Type
11.3.7.2.2 China Cardiac Marker Testing Market by Biomarker Type
11.3.7.2.3 China Cardiac Marker Testing Market by Application
11.3.7.2.4 China Cardiac Marker Testing Market by End User
11.3.7.3 India Cardiac Marker Testing Market
11.3.7.3.1 India Cardiac Marker Testing Market by Product Type
11.3.7.3.2 India Cardiac Marker Testing Market by Biomarker Type
11.3.7.3.3 India Cardiac Marker Testing Market by Application
11.3.7.3.4 India Cardiac Marker Testing Market by End User
11.3.7.4 Japan Cardiac Marker Testing Market
11.3.7.4.1 Japan Cardiac Marker Testing Market by Product Type
11.3.7.4.2 Japan Cardiac Marker Testing Market by Biomarker Type
11.3.7.4.3 Japan Cardiac Marker Testing Market by Application
11.3.7.4.4 Japan Cardiac Marker Testing Market by End User
11.3.7.5 South Korea Cardiac Marker Testing Market
11.3.7.5.1 South Korea Cardiac Marker Testing Market by Product Type
11.3.7.5.2 South Korea Cardiac Marker Testing Market by Biomarker Type
11.3.7.5.3 South Korea Cardiac Marker Testing Market by Application
11.3.7.5.4 South Korea Cardiac Marker Testing Market by End User
11.3.7.6 Rest of Asia-Pacific Cardiac Marker Testing Market
11.3.7.6.1 Rest of Asia-Pacific Cardiac Marker Testing Market by Product Type
11.3.7.6.2 Rest of Asia-Pacific Cardiac Marker Testing Market by Biomarker Type
11.3.7.6.3 Rest of Asia-Pacific Cardiac Marker Testing Market by Application
11.3.7.6.4 Rest of Asia-Pacific Cardiac Marker Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Cardiac Marker Testing Market Overview
11.4.2 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.4.5 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Cardiac Marker Testing Market
11.4.7.1.1 South Africa Cardiac Marker Testing Market by Product Type
11.4.7.1.2 South Africa Cardiac Marker Testing Market by Biomarker Type
11.4.7.1.3 South Africa Cardiac Marker Testing Market by Application
11.4.7.1.4 South Africa Cardiac Marker Testing Market by End User
11.4.7.2 Saudi Arabia Cardiac Marker Testing Market
11.4.7.2.1 Saudi Arabia Cardiac Marker Testing Market by Product Type
11.4.7.2.2 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type
11.4.7.2.3 Saudi Arabia Cardiac Marker Testing Market by Application
11.4.7.2.4 Saudi Arabia Cardiac Marker Testing Market by End User
11.4.7.3 U.A.E Cardiac Marker Testing Market
11.4.7.3.1 U.A.E Cardiac Marker Testing Market by Product Type
11.4.7.3.2 U.A.E Cardiac Marker Testing Market by Biomarker Type
11.4.7.3.3 U.A.E Cardiac Marker Testing Market by Application
11.4.7.3.4 U.A.E Cardiac Marker Testing Market by End User
11.4.7.4 Rest of Middle East and Africa Cardiac Marker Testing Market
11.4.7.4.1 Rest of Middle East and Africa Cardiac Marker Testing Market by Product Type
11.4.7.4.2 Rest of Middle East and Africa Cardiac Marker Testing Market by Biomarker Type
11.4.7.4.3 Rest of Middle East and Africa Cardiac Marker Testing Market by Application
11.4.7.4.4 Rest of Middle East and Africa Cardiac Marker Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Cardiac Marker Testing Market Overview
11.5.2 South and Central America Cardiac Marker Testing Market Forecasts and Analysis
11.5.3 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.5.5 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.5.6 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Cardiac Marker Testing Market
11.5.7.1.1 Brazil Cardiac Marker Testing Market by Product Type
11.5.7.1.2 Brazil Cardiac Marker Testing Market by Biomarker Type
11.5.7.1.3 Brazil Cardiac Marker Testing Market by Application
11.5.7.1.4 Brazil Cardiac Marker Testing Market by End User
11.5.7.2 Argentina Cardiac Marker Testing Market
11.5.7.2.1 Argentina Cardiac Marker Testing Market by Product Type
11.5.7.2.2 Argentina Cardiac Marker Testing Market by Biomarker Type
11.5.7.2.3 Argentina Cardiac Marker Testing Market by Application
11.5.7.2.4 Argentina Cardiac Marker Testing Market by End User
11.5.7.3 Rest of South and Central America Cardiac Marker Testing Market
11.5.7.3.1 Rest of South and Central America Cardiac Marker Testing Market by Product Type
11.5.7.3.2 Rest of South and Central America Cardiac Marker Testing Market by Biomarker Type
11.5.7.3.3 Rest of South and Central America Cardiac Marker Testing Market by Application
11.5.7.3.4 Rest of South and Central America Cardiac Marker Testing Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CARDIAC MARKER TESTING MARKET, KEY COMPANY PROFILES
13.1. ROCHE DIAGNOSTICS LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT LABORATORIES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SIEMENS HEALTHINEERS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DANAHER CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ORTHO CLINICAL DIAGNOSTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RANDOX LABORATORIES LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BIOMéRIEUX SA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LSI MEDIENCE CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. DIASORIN S.P.A.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIO-RAD LABORATORIES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Roche Diagnostics Ltd
2. Abbott Laboratories
3. Siemens Healthineers AG
4. Danaher Corporation
5. Ortho Clinical Diagnostics
6. Randox laboratories Ltd.
7. bioMérieux SA
8. LSI Medience Corporation
9. DiaSorin S.p.A.
10. Bio-Rad Laboratories, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For